DOW JONES27,960.80-1031.61 -3.56%
S&P 5003,225.89-111.86 -3.35%
NASDAQ9,221.28-355.31 -3.71%

Neurocrine Biosciences Q4 EPS $0.35 Misses $0.75 Estimate, Sales $237.9M Beat $230.94M Estimate

Neurocrine Biosciences (NASDAQ:NBIX) reported quarterly earnings of $0.35 per share which missed the analyst consensus estimate of $0.75 by 53.33 percent. This is a 84.21 percent increase over earnings of $0.19 per share

Benzinga · 02/04/2020 21:04

Neurocrine Biosciences (NASDAQ:NBIX) reported quarterly earnings of $0.35 per share which missed the analyst consensus estimate of $0.75 by 53.33 percent. This is a 84.21 percent increase over earnings of $0.19 per share from the same period last year. The company reported quarterly sales of $237.9 million which beat the analyst consensus estimate of $230.94 million by 3.01 percent. This is a 80.92 percent increase over sales of $131.492 million the same period last year.